AVITA Medical, Inc. (RCEL) EPS (Basic) (2018 - 2026)

AVITA Medical (RCEL) has reported EPS (Basic) for 9 consecutive years, with -$0.25 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EPS (Basic) rose 33.76% year-over-year to -$0.25; the trailing twelve-month figure through Jun 2026 stood at -$1.05 (up 28.41% YoY), and the FY2025 full-year result was -$1.38, up 26.97% from the prior year.
• EPS (Basic) eased to -$0.25 in Q2 2026 per RCEL's latest filing, from -$0.05 in the prior quarter.
• Across five years, EPS (Basic) topped out at $0.06 in Q4 2024 and bottomed at -$0.73 in Q1 2024.
• Historically, EPS (Basic) has averaged -$0.36 across 5 years, with a median of -$0.37 in 2023.
• The sharpest annual moves came in 2024 and 2025: EPS (Basic) surged 115.74% in 2024, then plunged 190.84% in 2025.
• Over 5 years, EPS (Basic) stood at -$0.17 in 2022, then slumped by 112.04% to -$0.35 in 2023, then soared by 115.74% to $0.06 in 2024, then slumped by 190.84% to -$0.05 in 2025, then tumbled by 392.77% to -$0.25 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered -$0.25, -$0.05, and -$0.46 for Q2 2026, Q4 2025, and Q3 2025 respectively.